Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR) appointed Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America effective Dec. 16, 2025.

Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region as Synergy advances international growth. The company established a wholly owned Mexico subsidiary in May 2025 and began initial shipments of supplement products to Costco Mexico this week. Colmenares has 18+ years of regional experience including roles at Procter & Gamble and Victus/Megalabs.

Key Figures

Industry experience over 18 years Pedro Colmenares’ experience across pharmaceutical and consumer health sectors

Market Reality Check

$1.88 Last Close

Volume Volume 44,480 is 43% above the 20-day average of 31,045, indicating elevated interest ahead of the expansion update. normal

Technical Shares at $1.96 are trading below the 200-day moving average of $2.55, despite the positive regional growth announcement.

Peers on Argus 1 Up 1 Down

SNYR gained 8.29% while key peers were mixed: ZYXI fell 9.54%, COSM slipped 1.54%, YI and QIPT were modestly down, and EDAP rose 12.97%. Momentum scanner peers showed ADGM up 13.08% and ZYXI down sharply, suggesting stock-specific factors for SNYR rather than a broad sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 13	Q3 2025 earnings	Positive	-6.4%	Reported 11th straight profitable quarter with higher revenue and margins.
Nov 05	Distribution partnership	Positive	+4.6%	Announced new C&M Sales partnership to expand FOCUSfactor beverages in Arkansas.
Oct 30	Earnings call notice	Neutral	+3.1%	Set date and time for Q3 2025 results release and conference call.
Oct 27	Brand recognition	Positive	-3.3%	FOCUSfactor named #1 pharmacist recommended OTC memory supplement for 2025-2026.
Oct 22	Retail expansion	Positive	+6.3%	Disclosed expanded FOCUSfactor distribution across major U.S., Canadian and global retailers.

Pattern Detected

Recent news tends to move the stock on commercial expansion and branding wins, but earnings and recognition announcements have sometimes seen negative or contrary reactions.

Recent Company History

Over the last few months, Synergy has focused on profitability and distribution expansion. On Oct 22, it announced major new retail placements for FOCUSfactor across Kroger, Wakefern, Uniprix and PriceSmart. Subsequent news highlighted the brand being named the #1 pharmacist-recommended OTC memory supplement and detailed Q3 2025 earnings with an 11th consecutive profitable quarter. Today’s appointment of a dedicated sales and marketing leader for Mexico and Latin America extends this commercial build-out into international markets, following earlier Costco Mexico shipments.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-11-26

$100 million registered capacity

An effective S-3 shelf filed on Nov 26, 2025 authorizes up to $100 million of various securities, including a sales agreement prospectus for up to $5.69 million in common stock within that limit. This provides flexibility to raise capital for working capital, R&D, acquisitions and debt reduction in future offerings.

Market Pulse Summary

The stock moved -5.6% in the session following this news. A negative reaction despite the commercial expansion hire would contrast with past responses to distribution and branding updates, which have sometimes been positive. With shares at $1.96, already well below the $2.55 200-day average and far under the $5.74 52-week high, further downside could reflect concerns about execution in new markets or potential future use of the $100 million shelf, rather than the appointment itself.

Key Terms

wholly owned subsidiary financial

"Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry"

A wholly owned subsidiary is a company whose entire ownership is held by another company (the parent), so the parent controls decisions, operations, and finances. Think of it as a fully controlled branch that runs as its own legal entity but whose results flow straight into the parent’s financial statements; investors watch these structures because they affect consolidated revenue, risk exposure, and how profits, liabilities, and cash flow are allocated across the corporate group.

otc regulatory

"across the pharmaceutical, nutraceutical, OTC, and consumer health sectors"

OTC stands for "over-the-counter" and describes securities that trade directly between dealers or via dealer networks rather than on a formal stock exchange. It matters to investors because OTC listings typically have fewer reporting rules and lower trading volume, which can mean higher price swings, limited liquidity, and greater difficulty buying or selling shares—similar to shopping at a small flea market instead of a large, regulated supermarket.

omnichannel technical

"built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution"

A coordinated approach to selling and serving customers across all touchpoints—stores, websites, mobile apps, social media, and call centers—so the experience feels like one continuous conversation no matter where a customer interacts. For investors, omnichannel capability signals how well a company can attract and keep customers, turn interactions into sales, and use shared customer data to cut costs and boost revenue—making it a key driver of growth and competitive strength.

go-to-market technical

"lead commercial strategy, market expansion, and go-to-market execution across the region"

A go-to-market plan is the practical roadmap a company uses to introduce a product or service to customers, covering who the target buyers are, how the product will be sold or distributed, pricing, and the main marketing and sales messages. For investors, it shows how quickly and cost-effectively a business can win customers and generate revenue — like a launch playbook that determines whether a new offering will reach its audience and scale profitably.

AI-generated analysis. Not financial advice.

Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico

WESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that Pedro Colmenares has been appointed Director of Sales & Marketing for Mexico & Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region.

Mr. Colmenares joins the Company at a pivotal time as it advances its international growth strategy. As announced in May 2025, Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry through shipments of its supplement products to Costco Mexico this week. As Director of Sales and Marketing for Mexico and Latin America, he will play a central role in executing this strategy and driving growth across both the Company’s supplement and functional beverage portfolios, building a scalable commercial foundation to support long-term growth.

“We’re excited to welcome Pedro to the Synergy team as we accelerate our expansion in Mexico and the broader Latin American market,” said Jack Ross, CEO of Synergy CHC Corp. “He brings deep regional expertise and a proven ability to build scalable commercial platforms from the ground up. His experience launching operations, developing distribution networks, and driving sustainable growth across Latin America will be instrumental as we establish and expand our presence in these high-potential markets.”

Mr. Colmenares is a senior commercial executive with over 18 years of experience across the pharmaceutical, nutraceutical, OTC, and consumer health sectors. He has successfully led market entry and expansion initiatives throughout Mexico and Latin America, consistently transforming underdeveloped markets into high-performing, sustainable businesses. His background includes leadership roles at Procter & Gamble and Victus/Megalabs, where he built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution.

Throughout his career, Mr. Colmenares has launched and developed operations in multiple countries across Latin America, driving accelerated growth through disciplined go-to-market strategies, localized brand development, and strong retailer and supplier relationships. His experience spans both multinational and regional organizations, providing a deep understanding of the operational and cultural dynamics required to scale consumer health brands in the region.

Pedro Colmenares commented: “I’m excited to join Synergy at such an important stage in the Company’s expansion. Synergy’s flagship FOCUSfactor brand, combined with its commitment to disciplined growth and local execution, presents a compelling opportunity. I look forward to building strong partnerships and helping drive meaningful, sustainable growth across Mexico and Latin America.”

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor^® and Flat Tummy^®. FOCUSfactor^®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada, and the U.K. through major retailers including Costco, Walmart, Amazon, BJ's, and Walgreens, among others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains in late 2025. Flat Tummy^® complements Synergy's portfolio as a lifestyle brand focused on women's wellness and weight management.

Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com

FAQ

Who is Pedro Colmenares and what role was he hired for at Synergy (SNYR)?

Pedro Colmenares was appointed Director of Sales & Marketing for Mexico & Latin America, responsible for commercial strategy and market expansion.

When did Synergy (SNYR) announce the appointment of Pedro Colmenares?

The appointment was announced on December 16, 2025.

What recent market steps has Synergy (SNYR) taken in Mexico?

Synergy established a wholly owned subsidiary in Mexico in May 2025 and began initial shipments to Costco Mexico this week.

How much regional experience does the new director have relevant to Synergy (SNYR)?

Mr. Colmenares has over 18 years of experience across pharmaceutical, nutraceutical, OTC, and consumer health sectors in Latin America.

Which Synergy product lines will Pedro Colmenares focus on in Mexico and Latin America?

He will focus on the company’s supplement and functional beverage portfolios, including the FOCUSfactor brand.

How will Pedro Colmenares support Synergy’s expansion in Latin America?

He will build commercial strategy, distribution networks, and go-to-market execution to scale operations and drive growth across the region.